13-102640299-C-G
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_001330588.2(TPP2):c.1943C>G(p.Ala648Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000548 in 1,459,756 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A648D) has been classified as Uncertain significance.
Frequency
Consequence
NM_001330588.2 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 78 with autoimmunity and developmental delayInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001330588.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TPP2 | NM_001330588.2 | MANE Select | c.1943C>G | p.Ala648Gly | missense | Exon 16 of 30 | NP_001317517.1 | ||
| TPP2 | NM_001367947.1 | c.1943C>G | p.Ala648Gly | missense | Exon 16 of 30 | NP_001354876.1 | |||
| TPP2 | NM_003291.4 | c.1943C>G | p.Ala648Gly | missense | Exon 16 of 29 | NP_003282.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TPP2 | ENST00000376052.5 | TSL:5 MANE Select | c.1943C>G | p.Ala648Gly | missense | Exon 16 of 30 | ENSP00000365220.3 | ||
| TPP2 | ENST00000376065.8 | TSL:1 | c.1943C>G | p.Ala648Gly | missense | Exon 16 of 29 | ENSP00000365233.4 | ||
| TPP2 | ENST00000651544.1 | c.1931C>G | p.Ala644Gly | missense | Exon 16 of 27 | ENSP00000498728.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 250948 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1459756Hom.: 0 Cov.: 30 AF XY: 0.00000964 AC XY: 7AN XY: 726166 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 648 of the TPP2 protein (p.Ala648Gly). This variant is present in population databases (rs769874271, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TPP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 570390). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at